AV
A. Volkovreader
4hBookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Twelve of 13 claims on rapamycin's mechanism, mouse data, and PEARL safety markers are supported. One claim about ideal weekly dosing remains hedged — the trial data isn't there yet.
Native comments, Twitter mentions, and Reddit threads about this content — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.